IPHA logo

Innate Pharma SA (IPHA) EBITDA

Annual EBITDA

-$1.99 M
+$10.96 M+84.63%

December 31, 2023

Summary

Performance

1-Year Change

+84.63%

3-Year Change

-103.1%

5-Year Change

-116.5%

15-Year Change

+95.96%

IPHA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

76.67%
IPHA annual EBITDA is higher than 76.67% of companies in Healthcare sector

High & Low

All-time High

$64.31 M
IPHA annual EBITDA is currently -103.10% below its historical high of $64.31 million

3-Year Low

-$48.00 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
IPHA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 27, 2025
IPHA next annual earnings announcement is scheduled for Mar 27, 2025

OtherIPHAprofitabilitymetrics:

Annual Revenue

$56.19 M
IPHA annual revenue is $56.19 million

Annual Net Income

-$8.20 M
IPHA annual net profit is -$8.20 million

Annual EBIT

-$7.50 M
IPHA annual earnings before interest & taxes is -$7.50 million

Annual EPS

-$0.10
IPHA annual earnings per share is -$0.10

Quarterly EBITDA

N/A

June 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

IPHA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$74.70 M
IPHA quarterly EBITDA is currently at an all-time high

3-Year Low

-
IPHA quarterly EBITDA 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
IPHA previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
IPHA next earnings announcement is scheduled for Mar 27, 2025

OtherIPHAprofitabilitymetrics:

Quarterly Revenue

-
IPHA quarterly revenue value is unknown

Quarterly Net Income

-
IPHA quarterly net profit value is unknown

Quarterly EBIT

-
IPHA quarterly earnings before interest & taxes value is unknown

Quarterly EPS

-
IPHA quarterly earnings per share value is unknown

TTM EBITDA

N/A

June 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

IPHA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$258.98 M
IPHA TTM EBITDA is currently at an all-time high

3-Year Low

-
IPHA TTM EBITDA 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
IPHA previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
IPHA next earnings announcement is scheduled for Mar 27, 2025

OtherIPHAprofitabilitymetrics:

TTM Revenue

-
IPHA TTM revenue value is unknown

TTM Net Income

-
IPHA TTM net profit value is unknown

TTM EBIT

-
IPHA TTM earnings before interest & taxes value is unknown

TTM EPS

-
IPHA TTM earnings per share value is unknown

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$1.99 M
IPHA annual EBITDA is -$1.99 million

Annual Net Income

-$8.20 M
IPHA annual net profit is -$8.20 million

Annual Interest Expense

$692.90 K
IPHA annual interest expense is $692.90 thousand

Annual Income Tax

$0.00
IPHA annual income tax is $0.00

Annual D&A

$5.51 M
IPHA annual depreciation & amortization is $5.51 million

IPHA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+84.6%--
3 y3 years-103.1%--
5 y5 years-116.5%--

IPHA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+95.8%
5 y5-year-103.1%+95.8%
alltimeall time-103.1%+96.0%

Innate Pharma SA EBITDA History

DateAnnualQuarterlyTTM
Dec 2023
-$1.99 M(-84.6%)
-
-
Dec 2022
-$12.95 M(-73.0%)
-
-
Dec 2021
-$48.00 M(-174.6%)
-
-
Apr 2021
-
$58.98 M(+5.6%)
$258.98 M(+1.5%)
Jan 2021
-
$55.87 M(-19.5%)
$255.11 M(+6.9%)
Dec 2020
$64.31 M(+133.5%)
-
-
Oct 2020
-
$69.43 M(-7.0%)
$238.71 M(+9.2%)
Jul 2020
-
$74.70 M(+35.5%)
$218.57 M(+11.3%)
Apr 2020
-
$55.11 M(+39.6%)
$196.33 M(+11.8%)
Jan 2020
-
$39.47 M(-19.9%)
$175.62 M(+1.8%)
Dec 2019
$27.54 M(+128.2%)
-
-
Oct 2019
-
$49.29 M(-6.0%)
$172.56 M(-4.1%)
Jul 2019
-
$52.46 M(+52.5%)
$180.02 M(-7.9%)
Apr 2019
-
$34.39 M(-5.6%)
$195.37 M(+21.4%)
Jan 2019
-
$36.42 M
$160.98 M
DateAnnualQuarterlyTTM
Dec 2018
$12.07 M(-124.5%)
-
-
Oct 2018
-
$56.74 M(-16.3%)
$124.56 M(+83.7%)
Jul 2018
-
$67.81 M
$67.81 M
Dec 2017
-$49.27 M(-372.7%)
-
-
Dec 2016
$18.07 M(-516.3%)
-
-
Dec 2015
-$4.34 M(-81.0%)
-
-
Dec 2014
-$22.79 M(+843.9%)
-
-
Dec 2013
-$2.41 M(-12.0%)
-
-
Dec 2012
-$2.74 M(-66.1%)
-
-
Dec 2011
-$8.09 M(-49.4%)
-
-
Dec 2010
-$15.97 M(-20.8%)
-
-
Dec 2009
-$20.17 M(+10.2%)
-
-
Dec 2008
-$18.31 M(+57.1%)
-
-
Dec 2007
-$11.66 M(+33.7%)
-
-
Dec 2006
-$8.72 M(+14.6%)
-
-
Dec 2005
-$7.61 M
-
-

FAQ

  • What is Innate Pharma SA annual EBITDA?
  • What is the all time high annual EBITDA for Innate Pharma SA?
  • What is Innate Pharma SA annual EBITDA year-on-year change?
  • What is the all time high quarterly EBITDA for Innate Pharma SA?
  • What is the all time high TTM EBITDA for Innate Pharma SA?

What is Innate Pharma SA annual EBITDA?

The current annual EBITDA of IPHA is -$1.99 M

What is the all time high annual EBITDA for Innate Pharma SA?

Innate Pharma SA all-time high annual EBITDA is $64.31 M

What is Innate Pharma SA annual EBITDA year-on-year change?

Over the past year, IPHA annual EBITDA has changed by +$10.96 M (+84.63%)

What is the all time high quarterly EBITDA for Innate Pharma SA?

Innate Pharma SA all-time high quarterly EBITDA is $74.70 M

What is the all time high TTM EBITDA for Innate Pharma SA?

Innate Pharma SA all-time high TTM EBITDA is $258.98 M